NCT07378761 2026-01-30
CHILURSO
University Hospital, Montpellier
Phase 2 Not yet recruiting
Clinical Trials
11 trialsNCT00873275 2025-06-22
Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
City of Hope Medical Center
Phase 1 Completed
NCT06918080 2025-04-09
Hepatoprotective Measures for Children at High Risk of NAFLD
Ain Shams University
Phase 4 Active not recruiting
NCT06842472 2025-02-24
PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT01505569 2024-02-26
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Masonic Cancer Center, University of Minnesota
Phase NA Completed
NCT04810156 2022-12-14
I-HEP
Herlev Hospital
Phase 2 Unknown
NCT01097304 2017-12-19
Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia
National Cancer Institute (NCI)
Phase 2 Completed
NCT01149304 2017-11-20
ELDORADO
University of Magdeburg
Phase 2 Completed
NCT00808743 2013-05-16
PreDuoFAP
Radboud University Medical Center
Phase 2/3 Completed
NCT00062023 2012-07-30
Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00134758 2009-07-29
Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients
Assistance Publique - Hôpitaux de Paris
Phase 2/3 Unknown